Announcement:

Submit your Center of Excellence Application today!

Read More

Resources

May 8, 2020

Regeneron says antibody for COVID-19 could be ready this year

Two antibody cocktails for COVID-19 could be available as early as this autumn

Regeneron says antibody for COVID-19 could be ready this year

Two antibody cocktails for COVID-19 could be available as early as this autumn
Regeneron has kicked off an accelerated development programme for two antibody cocktails for COVID-19 that could be available as early as this autumn – assuming it works as hoped in clinical trials. Those trials should get underway in June, according to Regeneron chief scientific officer George Yancopoulos, who told investors on a conference call that the drugs have emerged from the same antibody discovery platform as its Ebola drug EB3, which is heading towards an FDA verdict in October. The biotech is simultaneously working to rapidly scale-up manufacturing of the drug with a goal to have ‘hundreds of thousands’ of doses of the two cocktails available by the end of August. They have been selected from thousands of potent antiviral fully human antibodies generated against the coronavirus, said Yancopolous. “With Ebola, we set the record of nine months from initiating the project to starting human trials. Now, we hope to break that record with five months from project initiation to the clinic,” he added. The hope is that the antibodies could be used both to prevent infection and treat people who are already infected with SARS-CoV-2, the virus that causes COVID-19. “We think that there’s a very significant chance that these specifically designed, very potent neutralising antibodies will have a significant impact on the disease,” said Yancopolous…… Read more: https://www.pmlive.com/pharma_news/regeneron_says_antibody_for_covid-19_could_be_ready_this_year_1339947 Source: PM Live

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.